← Back to Search

Enhanced Care Coordination for Head and Neck Cancer (ECC Trial)

N/A

Recruiting

Research Sponsored by University of Pittsburgh

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with primary, squamous cell carcinoma of the paranasal sinuses, nasal cavity, oral cavity, tongue, salivary glands, larynx, and pharynx (including the nasopharynx, oropharynx, and hypopharynx)

Age 18 and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up start of treatment to 3 month post treatment completion

Awards & highlights

ECC Trial Summary

This trial is testing whether a new symptom management intervention can help reduce hospital visits for people with head and neck cancer.

Who is the study for?

This trial is for adults over 18 with primary squamous cell carcinoma in areas like the sinuses, nasal cavity, mouth, tongue, salivary glands, larynx or pharynx. It's also open to those with this cancer type found in lymph nodes from an unknown source. Participants must be starting radiation at Hillman Cancer Center and have not had prior radiation for these cancers.Check my eligibility

What is being tested?

The study tests a special program designed to manage symptoms better for head and neck cancer survivors undergoing radiation alone or with chemotherapy. The goal is to lessen symptom burden and reduce hospital visits.See study design

What are the potential side effects?

Since the intervention involves symptom assessment rather than medication or medical procedures, direct side effects are minimal. However, participants may experience discomfort discussing their symptoms.

ECC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a type of head or neck cancer.

Select...

I am 18 years old or older.

Select...

I have squamous cell carcinoma in my lymph nodes, but the original cancer location is unknown.

ECC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ start of treatment to 3 month post treatment completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~start of treatment to 3 month post treatment completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and start of treatment to 3 month post treatment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Emergency Room Visits

Inpatient Hospitalizations

Secondary outcome measures

Brief Pain Index (BPI)

Flourishing Measure

Malignant Neoplasms

+3 more

ECC Trial Design

1Treatment groups

Experimental Treatment

Group I: Head and neck cancer patientsExperimental Treatment1 Intervention

Patients from the Eye and Ear Institute Survivorship Clinic who are diagnosed with head and neck cancer.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor

1,720 Previous Clinical Trials

16,342,561 Total Patients Enrolled

Media Library

Symptom Assessment Clinical Trial Eligibility Overview. Trial Name: NCT04813172 — N/A

Head and Neck Cancers Research Study Groups: Head and neck cancer patients

Head and Neck Cancers Clinical Trial 2023: Symptom Assessment Highlights & Side Effects. Trial Name: NCT04813172 — N/A

Symptom Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT04813172 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the goal of this research endeavor?

"The primary outcome of this research, measured from the commencement to end-point of treatment over a 3 month span, will be Emergency Room Visits. Secondary assessments include the Brief Pain Index (BPI) which uses a 0-10 scale to evaluate pain severity and its impact on daily living; Hearing Handicap Inventory for Adults with answers ranging from 'Yes', 'Sometimes' or 'No'; and Flourishing Measure which consists of 10 questions regarding relationships, self-esteem, purpose and optimism with scores varying between 0 - 10 where higher values reflect greater psychological resources/strengths."

Answered by AI

What population is actively engaged in testing this clinical treatment?

"Affirmative. According to the information made available on clinicaltrials.gov, this medical trial is currently recruiting participants; it was posted online on August 1st 2020 and last edited on February 2nd 2022 with a goal of enrolling 400 patients at one trial location."

Answered by AI

Is the enrollment period for this research still accepting participants?

"Affirmative. Clinicaltrials.gov hosts information confirming the recruitment of 400 participants at a single site since January 8th 2020, with recent updates made on February 2nd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhanced Care Coordination for Head and Neck Cancer Survivors

Marci Nilsen 2020. "Enhanced Care Coordination for Head and Neck Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04813172.